Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
342.6 USD | -1.09% | -1.34% | +14.44% |
May. 10 | Bernstein Adjusts Price Target on Cigna to $411 From $389 | MT |
May. 06 | UBS Adjusts Cigna Price Target to $410 From $400, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 236B | Sales 2025 * | 247B | Capitalization | 98.41B |
---|---|---|---|---|---|
Net income 2024 * | 5.3B | Net income 2025 * | 7.16B | EV / Sales 2024 * | 0.51 x |
Net Debt 2024 * | 22.81B | Net Debt 2025 * | 19.26B | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
18.3
x | P/E ratio 2025 * |
13.2
x | Employees | 71,413 |
Yield 2024 * |
1.61% | Yield 2025 * |
1.73% | Free-Float | 69.59% |
Latest transcript on Cigna
1 day | -0.78% | ||
1 week | -0.08% | ||
Current month | -2.97% | ||
1 month | -0.98% | ||
3 months | +2.31% | ||
6 months | +19.42% | ||
Current year | +15.69% |
Managers | Title | Age | Since |
---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Brian Evanko
DFI | Director of Finance/CFO | 48 | - |
Paul Sanford
COO | Chief Operating Officer | - | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 17-12-31 | |
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Donna Zarcone
BRD | Director/Board Member | 66 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.33% | 8 M€ | +4.88% | ||
2.28% | 17 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 342.6 | -1.10% | 1 292 047 |
24-05-14 | 346.4 | -0.78% | 1,852,987 |
24-05-13 | 349.1 | +0.22% | 1,361,062 |
24-05-10 | 348.4 | -0.74% | 1,675,308 |
24-05-09 | 351 | +1.04% | 1,388,775 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.69% | 98.41B | |
-2.39% | 473B | |
+13.37% | 124B | |
+3.58% | 41.02B | |
-3.14% | 20.51B | |
-26.09% | 2.62B | |
-18.70% | 1.34B | |
+7.13% | 506M |
- Stock Market
- Equities
- CI Stock